By DAVID GELLES
With each tactical maneuver — the proposed board members being the latest — the hedge fund and Valeant continue to ratchet up the pressure on Allergan, best known as the maker of Botox.
Published: July 7, 2014 at 4:00AM
from NYT Business Day http://ift.tt/VT62F6
from WordPress http://ift.tt/1rImULD
via Hadi Aboukhater
No comments:
Post a Comment